Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.
Iula R, De Novellis D, Trastulli F, Della Pepa R, Fontana R, Carobene A, Di Perna M, D'Ambrosio A, Romano M, Leone A, De Fazio L, Fiumarella A, Gaeta G, Marafioti V, Barbato S, Palmieri S, Rocco S, Serio B, Califano C, Pane F, Ferrara F, Giudice V, Selleri C, Catalano L. Iula R, et al. Among authors: d ambrosio a, de novellis d, de fazio l. Front Oncol. 2022 Nov 15;12:1026251. doi: 10.3389/fonc.2022.1026251. eCollection 2022. Front Oncol. 2022. PMID: 36457484 Free PMC article.
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective.
Cacace F, Iula R, De Novellis D, Caprioli V, D'Amico MR, De Simone G, Cuccurullo R, Wierda WG, Mahadeo KM, Menna G, Tambaro FP. Cacace F, et al. Among authors: d amico mr, de simone g, de novellis d. Biomedicines. 2022 Jun 14;10(6):1405. doi: 10.3390/biomedicines10061405. Biomedicines. 2022. PMID: 35740427 Free PMC article. Review.
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study.
De Novellis D, Fontana R, Carobene A, Serio B, Ferrara I, Martorelli MC, Mettivier L, Guariglia R, Luponio S, Ruggiero I, D'Addona M, Di Leo T, Giudice V, Selleri C. De Novellis D, et al. Among authors: d addona m. Biomedicines. 2022 Jul 10;10(7):1657. doi: 10.3390/biomedicines10071657. Biomedicines. 2022. PMID: 35884962 Free PMC article.
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition.
Giudice V, Serio B, Errichiello S, Ferrara I, Galdiero A, Bertolini A, Visconti R, De Novellis D, Guariglia R, Luponio S, Morini D, Della Corte AM, Sessa AM, Verdesca F, Langella M, Izzo B, Selleri C. Giudice V, et al. Among authors: de novellis d. Eur J Haematol. 2023 Nov;111(5):729-741. doi: 10.1111/ejh.14069. Epub 2023 Jul 27. Eur J Haematol. 2023. PMID: 37501402
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
De Novellis D, Fontana R, Palmieri S, Della Pepa R, Di Perna M, Cetani G, Esposito D, Amendola A, Delle Cave G, Serio B, Morini D, Rizzo M, Mettivier L, Trastulli F, Rocco S, Pagano A, Barbato S, Leone A, La Magna M, Bianco R, Rascato G, Carobene A, Cuffa B, Iannalfo M, Giudice V, Svanera G, Annunziata M, Pizzuti M, Frigeri F, Califano C, Ferrara F, Pane F, Selleri C. De Novellis D, et al. Target Oncol. 2023 Nov;18(6):885-892. doi: 10.1007/s11523-023-01001-4. Epub 2023 Sep 25. Target Oncol. 2023. PMID: 37747623 Free PMC article.
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients.
De Novellis D, Folliero V, Giudice V, Pezzullo L, Sanna G, Fontana R, Guariglia R, Zannella C, Mettivier L, Ferrara I, Boccia G, Buonanno MT, Martorelli MC, Luponio S, Crudele A, Pagliano P, Sessa AM, Velino F, Langella M, Manzin A, Galdiero M, Selleri C, Franci G, Serio B. De Novellis D, et al. Clin Exp Med. 2023 Dec;23(8):4943-4953. doi: 10.1007/s10238-023-01223-w. Epub 2023 Oct 28. Clin Exp Med. 2023. PMID: 37898572 Free PMC article.
18 results